Abstract
The current trend in breast cancer treatment is toward breast conservation and selective use of axillary lymph node dissection. Patient eligibility criteria for treatment without axillary dissection are evolving. We retrospectively reviewed the tumor registry over a 10-year period at Naval Medical Center San Diego and included all women aged 70 and older with T1 breast carcinoma (n = 78). Data included tumor size, surgical therapy, post-operative therapy, recurrence, and survival. The women were divided into groups by the approach taken toward the axilla. No patient was given adjuvant chemotherapy. There were no axillary cancer recurrences in our patients. No statistically significant difference existed, regardless of the approach to the axilla, in recurrence or survival between groups. Axillary dissection in this population did not influence postoperative treatment, decrease recurrence, or improve survival. Our study suggests breast cancer treatment in this population should not include axillary dissection.
References
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·R SauerD Marx
Oct 1, 1990·Archives of Surgery·J H WongD L Morton
May 1, 1989·American Journal of Surgery·V RegerP C Jolly
May 1, 1989·Archives of Surgery·R G Margolese, R S Foster
Mar 14, 1985·The New England Journal of Medicine·B FisherE Montague
Dec 1, 1993·Archives of Surgery·B G HafftyJ J Fischer
Feb 1, 1994·Cancer·M J SilversteinP Gamagami
Apr 20, 1996·Lancet·R D GelberP Sevelda
Citations
Aug 14, 2002·Cancer·Stephen B EdgeUNKNOWN Outcomes and Preferences for Treatment in Older Women Nationwide Study Research Team
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M Noguchi
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NoguchiA Nonomura
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NoguchiN Tonami
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M NoguchiA Nonomura
Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Pauline T TruongIvo A Olivotto
Dec 22, 1999·Breast Cancer Research and Treatment·M NoguchiA Nonomura
Feb 28, 2009·Annals of Surgery·Anees B ChagparUNKNOWN North American Fareston Tamoxifen Adjuvant Trial
Dec 8, 2006·Annals of Surgical Oncology·Dalal AzizClaire M B Holloway
Mar 4, 2014·Annals of Surgical Oncology·Sara H JavidBenjamin O Anderson
Apr 13, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D GrabauL Rydén
Mar 3, 2004·Journal of Surgical Oncology·Marco GipponiFerdinando Cafiero
Aug 8, 2012·Current Problems in Cancer·Alan Adolph Thomay
Oct 31, 2006·Gynecologic Oncology·Tommaso SusiniGianfranco Scarselli
Jun 26, 2003·Journal of the American Geriatrics Society·Walter E Pofahl, Walter J Pories
Aug 18, 2005·American Journal of Surgery·Lisa E McMahonBarbara A Pockaj
Apr 29, 1998·American Journal of Surgery·J A Edney
Feb 19, 2000·Hematology/oncology Clinics of North America·G G Kimmick, L Balducci
Jun 22, 2001·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·P SchrenkW Wayand
Apr 4, 2003·The British Journal of Surgery·L Wyld, M W R Reed
Dec 6, 2002·Cancer·Jeanne S MandelblattJane C Weeks
Apr 15, 2004·British Journal of Cancer·L WyldM W R Reed
Oct 6, 2017·Oncotarget·Francesca Di SalvoUNKNOWN Socioeconomic Inequalities and Oncological Outcomes Italian Working Group
Jul 14, 2000·Annals of Surgical Oncology·L A DiFronzoA E Giuliano
Jul 10, 2021·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Mahaveer S SanghaMuneer Ahmed